Skip to content
healthcare.dev

ABILIFY

NDC 59148-008, ARIPIPRAZOLE, tablet, from Otsuka America Pharmaceutical, Inc..

Product NDC
59148-008
Status
Listed
Labeler
Otsuka America Pharmaceutical, Inc.
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA021436
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/59148-008 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • ARIPIPRAZOLE10 mg/1

Pharmacologic classes

Atypical Antipsychotic [EPC]

Package NDCNDC-11Package
59148-008-135914800081330 TABLET in 1 BOTTLE, PLASTIC (59148-008-13)
59148-008-3559148000835100 TABLET in 1 BLISTER PACK (59148-008-35)
59148-008-95591480008957 TABLET in 1 BLISTER PACK (59148-008-95)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/c040bd1d-45b7-49f2-93ea-aed7220b30ac
  • NADAC price for package 59148000813

    GET /v1/drugs/nadac/59148000813

Use it

Look up 59148-008 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/59148-008 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 59148-008. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.